| Target Price | $220.83 |
| Price | $178.88 |
| Potential | 23.45% |
| Number of Estimates | 60 |
| 60 Analysts have issued a price target NVIDIA 2026 . The average NVIDIA target price is $220.83. This is 23.45% higher than the current stock price. The highest price target is $409.22 128.77% , the lowest is $101.00 43.54% . | |
| A rating was issued by 71 analysts: 63 Analysts recommend NVIDIA to buy, 7 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the NVIDIA stock has an average upside potential 2026 of 23.45% . Most analysts recommend the NVIDIA stock at Purchase. |
68 Analysts have issued a sales forecast NVIDIA 2026 . The average NVIDIA sales estimate is $211b . This is 27.72% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $244b 47.65% , the lowest is $197b 19.00% .
This results in the following potential growth metrics:
| 2025 | $130b | 114.20% |
|---|---|---|
| 2026 | $211b | 61.70% |
| 2027 | $289b | 36.98% |
| 2028 | $359b | 24.23% |
| 2029 | $375b | 4.49% |
| 2030 | $429b | 14.37% |
| 2031 | $459b | 7.01% |
| 2032 | $565b | 23.06% |
| 2033 | $632b | 11.89% |
31 Analysts have issued an NVIDIA EBITDA forecast 2026. The average NVIDIA EBITDA estimate is $134b . This is 35.79% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $143b 44.89% , the lowest is $125b 26.28% .
This results in the following potential growth metrics and future EBITDA Margins:
| 2025 | $83.9b | 139.07% |
|---|---|---|
| 2026 | $134b | 59.96% |
| 2027 | $192b | 42.67% |
| 2028 | $220b | 14.79% |
| 2029 | $257b | 16.93% |
| 2030 | $354b | 37.65% |
| 2031 | $358b | 1.05% |
| 2032 | $359b | 0.46% |
| 2033 | $399b | 11.03% |
| 2025 | 64.31% | 11.61% |
|---|---|---|
| 2026 | 63.61% | 1.08% |
| 2027 | 66.25% | 4.15% |
| 2028 | 61.22% | 7.59% |
| 2029 | 68.51% | 11.91% |
| 2030 | 82.45% | 20.35% |
| 2031 | 77.86% | 5.57% |
| 2032 | 63.56% | 18.37% |
| 2033 | 63.07% | 0.77% |
68 NVIDIA Analysts have issued a net profit forecast 2026. The average NVIDIA net profit estimate is $112b . This is 29.55% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $134b 54.40% , the lowest is $101b 16.55% .
This results in the following potential growth metrics and future Net Margins:
| 2025 | $72.9b | 144.89% |
|---|---|---|
| 2026 | $112b | 53.94% |
| 2027 | $164b | 46.12% |
| 2028 | $208b | 26.59% |
| 2029 | $217b | 4.43% |
| 2030 | $250b | 15.28% |
| 2031 | $263b | 5.47% |
| 2032 | $333b | 26.39% |
| 2033 | $377b | 13.20% |
| 2025 | 55.85% | 14.33% |
|---|---|---|
| 2026 | 53.17% | 4.80% |
| 2027 | 56.71% | 6.66% |
| 2028 | 57.79% | 1.90% |
| 2029 | 57.76% | 0.05% |
| 2030 | 58.21% | 0.78% |
| 2031 | 57.37% | 1.44% |
| 2032 | 58.93% | 2.72% |
| 2033 | 59.62% | 1.17% |
68 Analysts have issued a NVIDIA forecast for earnings per share. The average NVIDIA EPS is $4.61 . This is 31.34% higher than earnings per share in the financial year 2025. The highest EPS forecast is $5.49 56.41% , the lowest is $4.15 18.23% .
This results in the following potential growth metrics and future valuations:
| 2025 | $2.94 | 147.06% |
|---|---|---|
| 2026 | $4.61 | 56.80% |
| 2027 | $6.73 | 45.99% |
| 2028 | $8.52 | 26.60% |
| 2029 | $8.90 | 4.46% |
| 2030 | $10.26 | 15.28% |
| 2031 | $10.82 | 5.46% |
| 2032 | $13.68 | 26.43% |
| 2033 | $15.48 | 13.16% |
| Current | 50.96 | 8.83% |
|---|---|---|
| 2026 | 39.20 | 23.83% |
| 2027 | 26.83 | 31.56% |
| 2028 | 21.19 | 21.02% |
| 2029 | 20.29 | 4.25% |
| 2030 | 17.60 | 13.26% |
| 2031 | 16.69 | 5.17% |
| 2032 | 13.21 | 20.85% |
| 2033 | 11.67 | 11.66% |
Based on analysts' sales estimates for 2026, the NVIDIA stock is valued at an EV/Sales of 20.57 and an P/S ratio of 20.80 .
This results in the following potential growth metrics and future valuations:
| Current | 26.02 | 14.49% |
|---|---|---|
| 2026 | 20.57 | 21.72% |
| 2027 | 15.02 | 27.00% |
| 2028 | 12.09 | 19.51% |
| 2029 | 11.57 | 4.30% |
| 2030 | 10.12 | 12.57% |
| 2031 | 9.45 | 6.55% |
| 2032 | 7.68 | 18.74% |
| 2033 | 6.87 | 10.62% |
| Current | 26.31 | 14.29% |
|---|---|---|
| 2026 | 20.80 | 21.70% |
| 2027 | 15.19 | 27.00% |
| 2028 | 12.22 | 19.51% |
| 2029 | 11.70 | 4.30% |
| 2030 | 10.23 | 12.57% |
| 2031 | 9.56 | 6.55% |
| 2032 | 7.77 | 18.74% |
| 2033 | 6.94 | 10.62% |
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Argus Research |
Buy
➜
Buy
|
Unchanged | Nov 20 2025 |
| Cantor Fitzgerald |
Overweight
➜
Overweight
|
Unchanged | Nov 20 2025 |
| Bernstein |
Outperform
➜
Outperform
|
Unchanged | Nov 20 2025 |
| Citigroup |
Buy
➜
Buy
|
Unchanged | Nov 20 2025 |
| Benchmark |
Buy
➜
Buy
|
Unchanged | Nov 20 2025 |
| Baird |
Outperform
➜
Outperform
|
Unchanged | Nov 20 2025 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Nov 20 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Argus Research:
Buy
➜
Buy
|
Nov 20 2025 |
|
Unchanged
Cantor Fitzgerald:
Overweight
➜
Overweight
|
Nov 20 2025 |
|
Unchanged
Bernstein:
Outperform
➜
Outperform
|
Nov 20 2025 |
|
Unchanged
Citigroup:
Buy
➜
Buy
|
Nov 20 2025 |
|
Unchanged
Benchmark:
Buy
➜
Buy
|
Nov 20 2025 |
|
Unchanged
Baird:
Outperform
➜
Outperform
|
Nov 20 2025 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Nov 20 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


